Investigating how malaria parasites control gene expression
RAPs-mediated post-transcriptional control in Apicomplexan parasites
This study is looking at how malaria parasites control their genes to grow and cause illness, and it hopes to find new ways to create medicines that can fight malaria without harming people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-10466864 on NIH RePORTER |
What this research studies
This research focuses on understanding the unique mechanisms that malaria parasites use to regulate their genes at the post-transcriptional level. By studying specific RNA-binding proteins (RAPs) that are unique to these parasites, the project aims to uncover how these proteins influence parasite development and virulence. The researchers will employ advanced molecular techniques to characterize these proteins and assess their potential as new targets for antimalarial drugs. This work could lead to innovative treatments that specifically target the malaria parasite without affecting human cells.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of malaria infection, particularly those living in endemic regions.
Not a fit: Patients who are not at risk of malaria or those who have already been effectively treated with existing antimalarial therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antimalarial drugs that are more effective and have fewer side effects.
How similar studies have performed: Previous research has shown promise in targeting unique molecular features of parasites, suggesting that this approach could lead to significant advancements in malaria treatment.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Le Roch, Karine Gaelle — University of California Riverside
- Study coordinator: Le Roch, Karine Gaelle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.